Literature DB >> 15541398

Non-induced leukocyte extract reduces HIV replication and TNF secretion.

Celia Fernández-Ortega1, Marta Dubed, Yudith Ramos, Leonor Navea, Giselle Alvarez, Leonor Lobaina, Lissette López, Dionne Casillas, Licet Rodríguez.   

Abstract

According to UNAIDS, the global HIV/AIDS epidemic increased to 40 million the number of people living with the virus around the world. Dialyzable leukocyte extract obtained by our group is a low molecular weight dialyzable material from peripheral human leukocytes previously in vitro induced with Sendai virus (DLE-ind), and more recently, from non-induced leukocytes (DLE n/i). Previous results have shown the ability of DLE-ind to inhibit HIV in vitro replication in MT4 cell; to reduce TNFalpha secretion, and to delay in vivo progression to AIDS in early stage of HIV infection. In this work we present evidences that DLE n/i also inhibits HIV in vitro replication and reduces TNFalpha secretion in human whole blood like DLE obtained from induced leukocytes. Taking together these results show that both properties of DLE, HIV in vitro inhibition and TNF production modulation, are not dependent on in vitro Sendai virus induction of leukocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541398     DOI: 10.1016/j.bbrc.2004.10.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis.

Authors:  Jessica Carmen; Jeffrey D Rothstein; Douglas A Kerr
Journal:  Brain Res       Date:  2009-02-03       Impact factor: 3.252

2.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01

3.  Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals.

Authors:  Carlos Guerra; Devin Morris; Andrea Sipin; Steven Kung; Mesharee Franklin; Dennis Gray; Michelle Tanzil; Frederick Guilford; Fadi T Khasawneh; Vishwanath Venketaraman
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

4.  High producer haplotype (CAG) of -863C/A, -308G/A and -238G/A polymorphisms in the promoter region of TNF-α gene associate with enhanced apoptosis of lymphocytes in HIV-1 subtype C infected individuals from North India.

Authors:  Sukhvinder Singh; Aman Sharma; Sunil K Arora
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

5.  Identification of Vimentin as a Potential Therapeutic Target against HIV Infection.

Authors:  Celia Fernández-Ortega; Anna Ramírez; Dionne Casillas; Taimi Paneque; Raimundo Ubieta; Marta Dubed; Leonor Navea; Lila Castellanos-Serra; Carlos Duarte; Viviana Falcon; Osvaldo Reyes; Hilda Garay; Eladio Silva; Enrique Noa; Yassel Ramos; Vladimir Besada; Lázaro Betancourt
Journal:  Viruses       Date:  2016-06-15       Impact factor: 5.048

Review 6.  Vimentin Diversity in Health and Disease.

Authors:  Frida Danielsson; McKenzie Kirsten Peterson; Helena Caldeira Araújo; Franziska Lautenschläger; Annica Karin Britt Gad
Journal:  Cells       Date:  2018-09-21       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.